About GlyTech
GlyTech is a company based in Kyoto (Japan) founded in 2012.. GlyTech has raised $9.14 million across 2 funding rounds from investors including Yokogawa, Osaka University and Nippon Shokubai. GlyTech operates in a competitive market with competitors including Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others.
- Headquarter Kyoto, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.14 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Yokogawa
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GlyTech
GlyTech has successfully raised a total of $9.14M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(28 May 2018)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series B - GlyTech | Valuation | Yokogawa |
|
| May, 2018 | Amount | Series A - GlyTech | Valuation | Nippon Shokubai , Fushimi Pharmaceutica |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GlyTech
GlyTech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Yokogawa, Osaka University and Nippon Shokubai. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funds are managed to support unlisted companies' growth.
|
Founded Year | Domain | Location | |
|
Cloud-based industrial automation and process control solutions are offered.
|
Founded Year | Domain | Location | |
|
Chemical catalysts and absorbents are manufactured by the company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GlyTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GlyTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glytech Comparisons
Competitors of GlyTech
GlyTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and assays for lipid biology research are manufactured.
|
|
| domain | founded_year | HQ Location |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| domain | founded_year | HQ Location |
High-throughput enzyme screening solutions are developed and provided.
|
|
| domain | founded_year | HQ Location |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
|
| domain | founded_year | HQ Location |
Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glytech
Frequently Asked Questions about GlyTech
When was GlyTech founded?
GlyTech was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is GlyTech located?
GlyTech is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Who is the current CEO of GlyTech?
Hiroaki Asai is the current CEO of GlyTech.
Is GlyTech a funded company?
GlyTech is a funded company, having raised a total of $9.14M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.14M, raised on May 28, 2018.
What does GlyTech do?
GlyTech was established in 2012 in Kyoto, Japan, within the biotechnology sector. Human-type asparagine-linked glycans are provided for research purposes. Operations center on glycan production and chemical glycosylation technologies, which are applied to medicine development, including biopharmaceuticals and oligonucleotide therapeutics. The companys activities support advancements in these therapeutic areas through specialized glycan solutions.
Who are the top competitors of GlyTech?
GlyTech's top competitors include Echelon Biosciences, Iceni Glycoscience and GlycoSpot.
Who are GlyTech's investors?
GlyTech has 6 investors. Key investors include Yokogawa, Osaka University, Nippon Shokubai, Fushimi Pharmaceutical, and Miat.